Multiple Cardiac Arrhythmias Detected by a Dual Chamber Implantable Cardioverter Defibrillator in a Patient with Hypertrophic Obstructive Cardiomyopathy

Hellenic Journal of Cardiology

Volumn 45, Issue 1, 2004, Pages 57-60

  Kassotis, John ^a   Haq, Salman ^a   Mongwa, Mbu ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Hypertrophic obstructive cardiomyopathy; Implantable cardioverter defibrillator; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; DIZZINESS; ELECTROCARDIOGRAM; EXERCISE TEST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PHYSICAL EXAMINATION; RISK FACTOR; SUDDEN DEATH; SYMPTOMATOLOGY; THORAX PAIN;

EID: 0842284109     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jeschke B, Uhl K, Weist B, et al: A high risk phenotype of hypertrophic cardiomyopathy associated with a compound phenotype of two mutated beta myosin heavy chains genes. Hum Genet 1998; 102: 299-304.
2. Lankford EB, Sweeney HL, Epstein ND, et al: Abnormal contractile properties of muscle fibers expressing mutations in beta-myosin in- patients with hypertrophic cardiomyopathy. J Clin Invest 1995; 95: 1409-1414.
3. Cuda G, Fanananpazir L, Epstein ND, et al: The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy-chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil 1997; 18: 1-19.
4. Maron, BJ, Lipson LC, Roberst WC, et al: Malignant hypertrophic cardiomyopathy: Identification of a subgroups of families with unusually frequent premature deaths. Am J Cardiol 1978; 14: 1133-1140.
5. McKenna WJ, Deabfield JE: Hypertrophic cardiomyopathy: An important cause of sudden cardiac death. Arch Dis Child 1984; 59: 971-975.
6. Maron BJ, Roberts WC, Epstein SE: Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982; 65: 1388-1394.
7. Maron BJ, Epstein SE, Roberts WC: Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986; 7: 204-214.
8. Maron BJ, Fananapazir L: Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992; 85: 157-163.
9. Savage DD, Sedes T, Maron BJ, et al: Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in-patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Circulation 1979; 59: 866-875.
10. Bjarnason I, Hadarson T, Jonsson S: Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J 1982; 48: 198-203.
11. Stafford WJ, Trohman RG, Bilsker M, et al: Cardiac arrest in adolescents with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 7: 701-704.
12. Fananapazir L, Epstein SE: VT and sudden death in HCM patients. Circulation 1989; 80: 1923-1934.
13. Fananapazir L, Chang AC, Epstein SE, et al: Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, holter, hemodynamics, and electrophysiologic findings. Circulation 1992; 86: 730-740.
14. Dilsizian V, Bonow RO, Epstein SE, et al: Myocardial ischemia is a frequent cause of cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. Circulation 1990; 82: 35A.
15. Anderson KP, Stinson EB, Derby GC, et al: Vulnerability of patients with hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Am J Cardiol 1983; 51: 811-815.
16. Spirito P, Rapezzi C, et al: Prognosis of asymptomatic patient with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation 1994; 90: 2743-2747.
17. rd ed, Zipes D, Jalife J; W.B. Saunders Company, 2000, pp 555-562
18. Spirito P, Marion BJ: Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 1521-1526.